LB-11 | Core-Laboratory Angiographic Characteristics and Mortality of Patients With STEMI and COVID-19: Insights from the NACMI Registry

Highlights From the Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions 2023

“…Payam Dehghani, MD discussed the North American COVID‐19 STEMI (NACMI) registry angiographic core lab findings. 33 This was the first blinded core lab analysis and the goal was to describe culprit lesion/artery characteristics, outline PCI outcomes, and associate core lab–determined angiographic characteristics with mortality. A total of 234 angiograms of patients with COVID‐19 and ST‐segment–elevation myocardial infarction, performed across 17 different sites in the United States and Canada, were analyzed.…”